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Background: Aggregatibacter bacteria are a rare cause of endocarditis in adults. They are part of a group of
organisms known as HACEK – Haemophilus, Aggregatibacter, Cardiobacter, Eikenella, and Kingella. Among these
organisms, several Haemophilus species have been reclassified under the genus Aggregatibacter. Very few cases of
Aggregatibacter endocarditis in patients with pacemaker devices have been reported.
Case presentation: We present here what we believe to be the first case of Aggregatibacter aphrophilus pacemaker
endocarditis. A 62-year-old African American male with a medical history significant for dual-chamber pacemaker
placement in 1996 for complete heart block with subsequent lead manipulation in 2007, presented to his primary
care doctor with fever, chills, night sweats, fatigue, and ten-pound weight loss over a four-month period. Physical
examination revealed a new murmur and jugular venous distension which prompted initiation of antibiotics for
suspicion of endocarditis. Both sets of initial blood cultures were positive for A. aphrophilus. Transesophageal
echocardiogram revealed vegetations on the tricuspid valve and the right ventricular pacemaker lead (Figure 1).
This case highlights the importance of identifying rare causes of endocarditis and recognizing that treatment may
not differ from the standard treatment for typical presentations. The patient received intravenous ceftriaxone for his
endocarditis for a total of six weeks. Upon device removal, temporary jugular venous pacing wires were placed.
After two weeks of antibiotic treatment and no clinical deterioration, a new permanent pacemaker was placed and
the patient was discharged home.
Conclusions: This is the first case of A. aphrophilus endocarditis in a patient with a permanent pacemaker. Our
patient had no obvious risk factors other than poor dentition and a history of repeated pacemaker lead
manipulation. This suggests that valvulopathies secondary to repeated lead manipulation can be clinically
significant factors in morbidity and mortality in this patient population.
Keywords: Endocarditis, HACEK, Pacemaker, Aggregatibacter, Haemophilus, CIEDBackground
Pacemaker endocarditis caused by Aggregatibacter spe-
cies is rarely described. We present a case of pacemaker
endocarditis secondary to Aggregatibacter aphrophilus,
an organism not previously described in the literature as
causing pacemaker endocarditis. Aggregatibacter species
are a member of the HACEK group of organisms, which
also include Haemophilus, Cardiobacter, Eikenella cor-
rodens, and Kingella. HACEK organisms are part of the
normal oropharyngeal flora, and typically account for
1-3% of native valve endocarditis [1,2]. In recent years,* Correspondence: npatel11@drexelmed.edu
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has increased. Unusually, the number of cardiovascular
implantable electronic device (CIED) infections has risen
by a greater proportion [3,4]. Endocarditis has been de-
scribed in up to 7-10% of cases of pacemaker-related in-
fections [3-6]. Typically, Staphylococci are the primary
organism responsible for CIED endocarditis [4]. Several
large retrospective reviews have not reported HACEK
endocarditis in patients with CIEDs [1,2], although there
have been case reports published [7-9].
Case presentation
The patient is a 62 year old African American male with
a medical history significant for complete heart block
treated with dual chamber pacemaker implantation ind. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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lar lead fracture with total left subclavian vein occlusion
necessitating lead placement in the right subclavian
vein. He initially presented to his primary care physician
with a four month history of subjective fevers, chills, night
sweats, vomiting, fatigue, decreased energy, and a ten
pound weight loss. Physical exam in the office revealed
a new systolic murmur consistent with tricuspid regur-
gitation (TR) and jugular venous distention (JVD). Blood
cultures were drawn as an outpatient. One week later,
blood cultures were positive for Aggregatibacter aphrophi-
lus, and the patient was told to go to the Emergency
Department (ED). In the ED the patient was afebrile,
with a heart rate of 70 beats/minute and a blood pres-
sure of 130/76 mmHg. His pulse oximetry was 96% on
room air. There was no erythema or tenderness over the
pacemaker pocket. A TR murmur and JVD were again
noted. No lesions were noted on the skin. Initial labora-
tory values showed a white blood cell count of 14,200
with a differential of 75% neutrophils, 17% lymphocytes,
and 1% monocytes. The erythrocyte sedimentation rate
was 91 mm/hour. A urinalysis was negative. Peripheral
blood cultures were also drawn; subsequently the patient
was given a dose of 3.375 g intravenous (IV) piperacillin/
tazobactam by the ED physician.
The patient was admitted to the general medical floor
with a high clinical suspicion of HACEK endocarditis
and antibiotics changed to ceftriaxone IV 2 g Q24 hours
based on outpatient culture susceptibilities that showed
beta lactamase negative strains susceptible to penicillin,
ampicillin, amoxicillin, gentamycin, ciprofloxacin, and
ceftriaxone. On the night of admission, the patient was
febrile with a temperature of 101 degrees F (38.3 C).Figure 1 Transesophageal echocardiogram showing a 1.2 × 0.7 cm ve
lead in the right atrium at the coaptation of the tricuspid valve leaf
RV = Right Ventricle.A stat transesophageal echocardiogram (TEE) revealed
a 1.2 cm × 0.7 cm vegetation attached to the posterior
leaflet of the tricuspid valve and a smaller vegetation at-
tached to the right ventricular pacemaker lead near the
coaptation of the tricuspid valve leaflets (Figure 1). He
underwent a pacemaker extraction with removal of his
device and all leads. Intraoperatively, lead sites and the
pocket were debrided with an antibiotic solution. Tissue
and extracted leads were also swabbed and cultured. Fol-
lowing extraction, a temporary jugular pacer was placed
and the patient was transferred to the Cardiac Care
Unit. On the fifth day after admission cultures confirmed
beta lactamase negative Aggregatibacter aphrophilus with
the same susceptibilities reported as outpatient blood
cultures.
Following lead extraction, the patient remained afe-
brile and clinically stable. Repeated blood cultures were
persistently negative. Echocardiography prior to new de-
vice placement showed residual casts on the tricuspid
valve and the junction of superior vena cava and right
atrium. A new dual chamber permanent pacemaker was
then surgically deployed. He remained stable and was
discharged five days later with a Hickman® catheter to
finish the remaining 28 days of ceftriaxone for a total of
42 days of antibiotics.
Discussion
Aggregatibacter aphrophilus, first described in 1940 by
Khairat and colleagues (initially as Haemophilus aphro-
philus) is a member of the group of HACEK organisms
[10]. Notably, Aggregatibacter aphrophilus now includes
species formerly known as H. paraphrophilus and H.
aphrophilus [11].getation (arrow) attached to the right ventricular pacemaker
lets. Ao = Aorta, TV = Tricuspid Valve, RVL = Right Ventricular Lead,
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small percentage of cases of endocarditis. The occur-
rence of HACEK organisms in CIED patients is limited
to case reports in the current literature. We believe that
our case is the first reported case of Aggregatibacter
aphrophilus endocarditis in a pacemaker-dependent pa-
tient. Typically Aggregatibacter aphrophilus is part of
normal oral flora and frequently found in dental pla-
ques and gingival scrapings [11,12]. Dental procedures,
tongue piercings, use of tongue scrapers, and recent
upper respiratory tract infections are known causes for
bacterial entry into the bloodstream [9,11]. In our case,
the patient did not report any of the above mentioned
factors. However, his exam was significant for markedly
poor dentition.
We theorize that the patient may have seeded the
bacteria while brushing his teeth. It is well known that
this activity increases the risk of transient bacteremia
several-fold [12,13], and given his lack of any other risk
factors, this seemed most plausible. Additionally, it is
thought that A. aphrophilus is similar to Streptococci
species in that it has a tendency to be virulent only in a
predisposed, structurally defective heart [12,14]. The
presence of pacemaker leads is known to cause tricus-
pid valvulopathy [15]. It is likely that our patient’s re-
peated lead manipulations caused a valvulopathy which
served as a nidus for bacterial seeding.
Our treatment method of A. aphrophilus pacemaker
endocarditis was similar to the treatment of pacemaker
endocarditis caused by other organisms. Upon device
removal, the patient was placed on temporary jugular
venous pacing. It was mentioned earlier that temporary
pacing is associated with increased risk for future infec-
tion; however it was necessary in our patient given a
history of complete heart block. Additionally, the pa-
tient received antibiotic treatment with ceftriaxone for
a total of six weeks in accordance with resulted sus-
ceptibilities and published guidelines [16]. After two
weeks of antibiotic treatment and no clinical deterior-
ation, a new permanent pacemaker was placed and the
patient was discharged home to finish 4 more weeks of
IV antibiotics
Conclusions
After a thorough literature search, we did not find any
other cases of A. aphrophilus endocarditis in a patient
with a permanent pacemaker. In addition, this organism
is a rare cause of endocarditis in the general population.
Our patient had no obvious risk factors other than poor
dentition and a history of repeated pacemaker lead ma-
nipulation. This suggests that valvulopathies secondary
to repeated lead manipulation can be clinically signifi-
cant factors in morbidity and mortality in this patient
population.Consent
Written informed consent was obtained from the patient
for publication of this Case Report and any accompany-
ing images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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